Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AM001 Cream 7.5% in Plaque Psoriasis
NCT03005964Phase 2Completed
- Sponsor
- AmDerma Pharmaceuticals
- Start
- Dec 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of potassium dobesilate in plaque psoriasis, sponsored by AmDerma Pharmaceuticals. Started Dec 2016; status: completed.
02
Drugs
potassium dobesilate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03005964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03005964.